Patents by Inventor Richard Greil

Richard Greil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical intervention in haematological cancers
    Patent number: 8501734
    Abstract: The present invention relates to the medical and pharmaceutical use of substituted 1H-imidazo[4,5-c]quinolin-4-amines, in particular Imiquimod® and Gardiquimod®, alone or preferably in combination with Akt inhibitors, in particular with Akti1/2 and AktX, and most preferably with Akti1/2, in the treatment, prevention and/or amelioration of haematological cancers, in particular multiple myeloma disorders or B-cell disorders, and most particular in the therapy of multiple myeloma.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: August 6, 2013
    Assignee: Oncotyrol-Center for Personalized Cancer Medicine GmbH (Ltd.)
    Inventors: Lukas Huber, Simon Schnaiter, Inge Tinhofer, Karin Jöhrer, Richard Greil
  • MEDICAL INTERVENTION IN HAEMATOLOGICAL CANCERS
    Publication number: 20110178076
    Abstract: The present invention relates to the medical and pharmaceutical use of substituted 1H-imidazo[4,5-c]quinolin-4-amines, in particular Imiquimod® and Gardiquimod®, alone or preferably in combination with Akt inhibitors, in particular with Akti1/2 and AktX, and most preferably with Akti1/2, in the treatment, prevention and/or amelioration of haematological cancers, in particular multiple myeloma disorders or B-cell disorders, and most particular in the therapy of multiple myeloma.
    Type: Application
    Filed: May 26, 2009
    Publication date: July 21, 2011
    Inventors: Lukas Huber, Simon Schnaiter, Inge Tinhofer, Karin Jöhrer, Richard Greil